Showing results (1-10 of 188) with videos related to
Sort By:
Pageof 19
Current Opinion in Pediatrics|February 17, 2000
Return of granulocyte transfusionsD C Dale, W C LilesCurrent Opinion in Hematology|April 17, 2001
Granulocyte transfusion therapy: update on potential clinical applicationsK Hübel, D C Dale, W C LilesTransfusion|June 24, 2000
Combined administration of G-CSF and dexamethasone for the mobilization of granulocytes in normal donors: optimization of dosingW C Liles, E Rodger, D C DaleBlood|October 15, 1995
Glucocorticoids inhibit apoptosis of human neutrophilsW C Liles, D C Dale, S J KlebanoffCytokines, Cellular & Molecular Therapy|December 7, 2000
Use of G-CSF for granulocyte transfusion therapyK Hübel, D C Dale, A Engert, et al.The Journal of Infectious Diseases|December 9, 2000
Current status of granulocyte (neutrophil) transfusion therapy for infectious diseasesK Hübel, D C Dale, A Engert, et al.American Journal of Hematology|January 10, 1998
Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil kinetics and function in normal human volunteersD C Dale, W C Liles, C Llewellyn, et al.Transfusion|August 26, 1998
Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasoneD C Dale, W C Liles, C Llewellyn, et al.The Journal of Infectious Diseases|March 9, 1999
Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogensJ M Gaviria, J A van Burik, D C Dale, et al.The Journal of Infectious Diseases|April 7, 1999
Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivoJ M Gaviria, J A van Burik, D C Dale, et al.Pageof 19